Literature DB >> 18358621

Selective tonicity-induced expression of the neutral amino-acid transporter SNAT2 in oligodendrocytes in rat brain following systemic hypertonicity.

S Maallem1, M Mutin, I M González-González, F Zafra, M L Tappaz.   

Abstract

Sodium-coupled neutral amino-acid transporter member 2 (SNAT2) belongs to the family of neutral amino-acid transporters. SNAT2 is encoded by the gene Slc38a2, whose expression was reported to increase in vitro in fibroblasts, endothelial and renal cells exposed to a hypertonic medium. SNAT2 tonicity-induced expression brings about cellular accumulation of amino-acid, which contributes to osmoadaptation to hypertonicity. Since brain osmoadaptation is observed in relationship to neurological disorders resulting from pathological osmotic imbalances in blood plasma, we have investigated, through immunocytochemistry, SNAT2 expression in brain of rats subjected to systemic hypertonicity. Following prolonged systemic hypertonicity (24 h), small, strongly immunolabeled elements were observed that were not present in sham-treated animals. They were evenly distributed in the gray matter, with a lower density in the forebrain and a higher density in the brain stem. However the highest density by far was observed in white matter, where they were frequently aligned in chain-like rows. These observations suggested an oligodendrocyte location that was further established by double immunofluorescent labeling, using the oligodendrocyte phenotypic markers 2'-3'-cyclic nucleotide 3'phosphodiesterase and carbonic anhydrase II. SNAT2-positive elements were found associated with oligodendrocyte cell bodies, while oligodendrocyte processes were devoid of labeling. A quantitative analysis performed in the cerebral cortex indicated that virtually all SNAT2-positive elements were associated with oligodendrocyte cell bodies and conversely that the overwhelming majority of oligodendrocytes showed SNAT2 immunolabeling. The tonicity-induced expression of SNAT2 was not observed following acute systemic hypertonicity (6 h). Our results suggest that the osmoadaptation of brain oligodendrocytes to hypertonicity relies upon amino-acid accumulation through the tonicity-induced expression of SNAT2. The possible significance of these findings in relationship to the selective loss of oligodendrocytes observed in osmotic demyelination syndrome is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358621     DOI: 10.1016/j.neuroscience.2008.01.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  eIF2alpha phosphorylation tips the balance to apoptosis during osmotic stress.

Authors:  Elena Bevilacqua; Xinglong Wang; Mithu Majumder; Francesca Gaccioli; Celvie L Yuan; Chuanping Wang; Xiongwei Zhu; Lindsay E Jordan; Donalyn Scheuner; Randal J Kaufman; Antonis E Koromilas; Martin D Snider; Martin Holcik; Maria Hatzoglou
Journal:  J Biol Chem       Date:  2010-03-25       Impact factor: 5.157

2.  SNAT2 amino acid transporter is regulated by amino acids of the SLC6 gamma-aminobutyric acid transporter subfamily in neocortical neurons and may play no role in delivering glutamine for glutamatergic transmission.

Authors:  Sukhjeevan Grewal; Norah Defamie; Xiong Zhang; Stéphanie De Gois; Ali Shawki; Bryan Mackenzie; Chu Chen; Hélène Varoqui; Jeffrey D Erickson
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

3.  Extra pontine osmotic demyelination syndrome.

Authors:  Pervaiz M Zunga; Omar Farooq; Mohd I Dar; Ishrat H Dar; Samia Rashid; Abdul Q Rather; Javid A Basu; Mohammed Ashraf; Jahangeer A Bhat
Journal:  Ann Neurosci       Date:  2015-01

Review 4.  Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective.

Authors:  Charles Nicaise; Catherine Marneffe; Joanna Bouchat; Jacques Gilloteaux
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

5.  Functional Consequences of Low Activity of Transport System A for Neutral Amino Acids in Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Martina Chiu; Giuseppe Taurino; Massimiliano G Bianchi; Erica Dander; Alessandra Fallati; Nicola Giuliani; Giovanna D'Amico; Ovidio Bussolati
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

6.  Impact of Inhibition of Glutamine and Alanine Transport on Cerebellar Glial and Neuronal Metabolism.

Authors:  Abhijit Das; Gregory Gauthier-Coles; Stefan Bröer; Caroline D Rae
Journal:  Biomolecules       Date:  2022-08-27

7.  Osmotic demyelination syndrome following slow correction of hyponatremia: Possible role of hypokalemia.

Authors:  Parvaiz A Koul; Umar Hafiz Khan; Rafi A Jan; Sanaullah Shah; Abdul Baseer Qadri; Burhan Wani; Mohammed Ashraf; Feroze Ahmad; Sajjad R Bazaz
Journal:  Indian J Crit Care Med       Date:  2013-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.